(Q34104302)

31 July 2017

1 reference

title

The use of silymarin in the treatment of liver diseases (English)

1 reference

31 July 2017

Saller R

1

1 reference

31 July 2017

Meier R

series ordinal

2

1 reference

31 July 2017

Brignoli R

series ordinal

3

1 reference

31 July 2017

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

61

1 reference

31 July 2017

2035-2063

1 reference

31 July 2017

14

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200161140-00003

31 July 2017

0 references

cites work

Comparative bioavailability of Silipide, a new flavanolignan complex, in rats

1 reference

12 December 2020

Aminotransferase levels and silymarin in de novo tacrine-treated patients with Alzheimer's disease.

1 reference

12 December 2020

[Elimination of silymarin by cholecystectomied patients. 2. Biliary elimination after multiple oral doses]

1 reference

12 December 2020

Silymarine during maintenance therapy of acute promyelocytic leukemia

1 reference

12 December 2020

Is liver fibrosis reversible?

1 reference

12 December 2020

Evidence-based medicine and critical care

1 reference

12 December 2020

The management of chronic hepatitis B infection

1 reference

12 December 2020

Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection

1 reference

12 December 2020

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

1 reference

12 December 2020

An adverse reaction to the herbal medication milk thistle (Silybum marianum). Adverse Drug Reactions Advisory Committee

1 reference

12 December 2020

Scavenging of reactive oxygen species and inhibition of arachidonic acid metabolism by silibinin in human cells

1 reference

12 December 2020

[Silymarin for the treatment of acute viral hepatitis? Report of a controlled trial (author's transl)]

1 reference

12 December 2020

A pilot study on the liver protective effect of silybin-phosphatidylcholine complex (IdB1016) in chronic active hepatitis

1 reference

12 December 2020

[Studies on elimination of silymarin in cholecystectomized patients. I. Biliary and renal elimination after a single oral dose]

1 reference

12 December 2020

Effect of free radical scavengers on superoxide dismutase (SOD) enzyme in patients with alcoholic cirrhosis

1 reference

12 December 2020

Free radicals as mediators of alcohol toxicity

1 reference

12 December 2020

Prevention of alloxan-induced diabetes mellitus in the rat by silymarin

1 reference

12 December 2020

Plasma concentrations of free and conjugated silybin after oral intake of a silybin-phosphatidylcholine complex (silipide) in healthy volunteers

1 reference

12 December 2020

Endogenous mono-ADP-ribosylation in retina and peripheral nervous system. Effects of diabetes

1 reference

12 December 2020

Treatment of Amanita mushroom poisoning: a review.

1 reference

12 December 2020

Protective effect of Legalon in workers exposed to organic solvents.

1 reference

12 December 2020

[Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients]

1 reference

12 December 2020

[Inhibitory effect of silybin on the activity of 5-lipoxygenase of the porcine cerebral basilar artery]

1 reference

12 December 2020

Treatment of mushroom poisoning

1 reference

12 December 2020

Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients

1 reference

12 December 2020

Effects of two bioflavonoids on certain cellular immune reactions in vitro

1 reference

12 December 2020

Serum pro-collagen III peptide levels are related to lobular necrosis in untreated patients with chronic hepatitis C.

1 reference

12 December 2020

[Treatment of acute alcoholic alcoholism]

1 reference

12 December 2020

Effects of silibinin and antioxidants on high glucose-induced alterations of fibronectin turnover in human mesangial cell cultures.

1 reference

12 December 2020

[Postoperative behavior of serum cholinesterase and other liver enzymes]

1 reference

12 December 2020

Toxic occupational liver diseases. Therapeutic effects of silymarin

1 reference

12 December 2020

[Silymarin-containing phytopharmaceuticals--biopharmacy as an essential therapeutic quality criterion]

1 reference

12 December 2020

A review of plants used in the treatment of liver disease: part 1

1 reference

12 December 2020

Milk thistle: Silybum marianum.

1 reference

12 December 2020

[Poisoning by mushrooms of the Amanita phalloides type]

1 reference

12 December 2020

Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis

1 reference

12 December 2020

[The solubility and bioequivalence of silymarin preparations]

1 reference

12 December 2020

Study on dose-linearity of the pharmacokinetics of silibinin diastereomers using a new stereospecific assay

1 reference

12 December 2020

[Drug clinics. Drug of the month. Legalon (silymarin)]

1 reference

12 December 2020

[Severe vomiting, diarrhea]

1 reference

12 December 2020

Selective inhibition of NF-kappaB activation by the flavonoid hepatoprotector silymarin in HepG2. Evidence for different activating pathways

1 reference

12 December 2020

Results of a double blind study on the effect of silymarin in the treatment of acute viral hepatitis, carried out at two medical centres (author's transl)

1 reference

12 December 2020

Which patients with hepatitis C develop liver complications?

1 reference

12 December 2020

A new inclusion complex of silibinin and beta-cyclodextrins: in vitro dissolution kinetics and in vivo absorption in comparison with traditional formulations

1 reference

12 December 2020

[Liver-protective action of silymarin therapy in chronic alcoholic liver diseases]

1 reference

12 December 2020

Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats

1 reference

12 December 2020

Hepatitis C virus: current understanding and prospects for future therapies

1 reference

12 December 2020

Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis.

1 reference

12 December 2020

Hepatoprotective and immunomodulatory effects of antioxidant therapy

1 reference

12 December 2020

Inhibitory effects of silibinin on cytochrome P-450 enzymes in human liver microsomes

1 reference

12 December 2020

Comparative effects of colchicine and silymarin on CCl4-chronic liver damage in rats

1 reference

12 December 2020

Predictors of one-year pretransplant survival in patients with cirrhosis.

1 reference

12 December 2020

Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients

1 reference

12 December 2020

[Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol)]

1 reference

12 December 2020

Prevention by silybin of phalloidin-induced acute hepatoxicity

1 reference

12 December 2020

Does alcohol directly stimulate pancreatic fibrogenesis? Studies with rat pancreatic stellate cells

1 reference

12 December 2020

IE and IgG antibodies against flavonoids following therapy with flavonoid-containing drugs

1 reference

12 December 2020

Silybin inhibition of amatoxin uptake in the perfused rat liver

1 reference

12 December 2020

Silibinin, a plant extract with antioxidant and membrane stabilizing properties, protects exocrine pancreas from cyclosporin A toxicity

1 reference

12 December 2020

Biochemical bases of the pharmacological action of the flavonoid silymarin and of its structural isomer silibinin.

1 reference

12 December 2020

Controlled study of the effect of silymarin on alcoholic liver disease

1 reference

12 December 2020

Inducers of cytochrome P450 2E1 enhance methotrexate-induced hepatocytoxicity

1 reference

12 December 2020

[The use of silymarin and SAMe in the treatment of acute infective hepatitis in childhood]

1 reference

12 December 2020

Hepatitis C: epidemiology and review of complementary/alternative medicine treatments

1 reference

12 December 2020

Prevention of CCL4-induced liver cirrhosis by silymarin

1 reference

12 December 2020

Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin

1 reference

12 December 2020

Influence of tumor necrosis factor-alpha and silibin on the cytotoxic action of alpha-amanitin in rat hepatocyte culture

1 reference

12 December 2020

Milk thistle (Silybum marianum) for the therapy of liver disease

1 reference

12 December 2020

Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double-blind controlled study

1 reference

12 December 2020

Chemotherapy of Amanita phalloides poisoning with intravenous silibinin

1 reference

12 December 2020

Scavenging of reactive oxygen species by silibinin dihemisuccinate

1 reference

12 December 2020

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

1 reference

12 December 2020

Antioxidants modulate acute solar ultraviolet radiation-induced NF-kappa-B activation in a human keratinocyte cell line

1 reference

12 December 2020

Care of patients with ascites

1 reference

12 December 2020

Results of two double-blind studies on the effect of silymarine in chronic hepatitis (author's transl)

1 reference

12 December 2020

Pharmacokinetic studies with silymarin in human serum and bile.

1 reference

12 December 2020

Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis.

1 reference

12 December 2020

Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver

1 reference

12 December 2020

[Non-alcoholic steato-hepatitis]

1 reference

12 December 2020

Pharmacokinetic studies on IdB 1016, a silybin- phosphatidylcholine complex, in healthy human subjects

1 reference

12 December 2020

[The importance of concomitant compounds in plant extracts]

1 reference

12 December 2020

Ethanol elimination in man under influence of hepatoprotective silibinin

1 reference

12 December 2020

Cytoprotection in the nineties: experience with ursodeoxycholic acid and silymarin in chronic liver disease

1 reference

12 December 2020

The treatment of chronic viral hepatitis

1 reference

12 December 2020

NF-kappa B-independent suppression of HIV expression by ascorbic acid

1 reference

12 December 2020

Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial.

1 reference

12 December 2020

Hepatoprotective mechanism of silymarin: no evidence for involvement of cytochrome P450 2E1.

1 reference

12 December 2020

Characterization of a transporting system in rat hepatocytes. Studies with competitive and non-competitive inhibitors of phalloidin transport

1 reference

12 December 2020

Softgel capsule technology as an enhancer device for the absorption of natural principles in humans. A bioavailability cross-over randomised study on silybin

1 reference

12 December 2020

10.2165/00003495-200161140-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference